X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2845) 2845
Publication (177) 177
Book Review (12) 12
Book Chapter (4) 4
Magazine Article (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2743) 2743
female (2571) 2571
middle aged (1681) 1681
aged (1348) 1348
index medicus (1254) 1254
adult (1229) 1229
ovarian neoplasms - pathology (1184) 1184
oncology (1142) 1142
cystadenocarcinoma, serous - pathology (1125) 1125
cancer (882) 882
ovarian cancer (806) 806
prognosis (732) 732
obstetrics & gynecology (727) 727
carcinoma (701) 701
neoplasm staging (650) 650
aged, 80 and over (605) 605
pathology (575) 575
tumors (524) 524
cystadenocarcinoma, serous - genetics (492) 492
retrospective studies (490) 490
immunohistochemistry (469) 469
ovarian neoplasms - genetics (466) 466
cystadenocarcinoma, serous - diagnosis (437) 437
surgery (428) 428
cystadenocarcinoma, serous - metabolism (427) 427
diagnosis, differential (420) 420
ovarian neoplasms - diagnosis (395) 395
ovarian neoplasms - metabolism (384) 384
chemotherapy (379) 379
cystadenocarcinoma, serous - surgery (370) 370
survival (355) 355
diagnosis (345) 345
male (333) 333
ovarian neoplasms - surgery (310) 310
follow-up studies (307) 307
survival rate (303) 303
cystadenocarcinoma, serous - mortality (300) 300
endometrial neoplasms - pathology (295) 295
expression (282) 282
ovarian neoplasms - mortality (277) 277
cystadenocarcinoma (264) 264
analysis (260) 260
adenocarcinoma (255) 255
ovarian neoplasms - drug therapy (255) 255
cystadenocarcinoma, serous - drug therapy (249) 249
neoplasm grading (243) 243
adenocarcinoma, clear cell - pathology (239) 239
research (215) 215
cystadenocarcinoma, papillary - pathology (212) 212
treatment outcome (211) 211
women (206) 206
adenocarcinoma, mucinous - pathology (205) 205
metastasis (203) 203
biomarkers, tumor - metabolism (201) 201
medicine & public health (192) 192
pancreatic neoplasms - pathology (192) 192
biomarkers, tumor - analysis (191) 191
obstetrics and gynecology (191) 191
care and treatment (190) 190
mutation (189) 189
adolescent (188) 188
ovary (186) 186
hematology, oncology and palliative medicine (183) 183
antineoplastic combined chemotherapy protocols - therapeutic use (182) 182
endometrial cancer (182) 182
ovarian carcinoma (182) 182
carcinoma, endometrioid - pathology (179) 179
tomography, x-ray computed (178) 178
young adult (175) 175
cystadenocarcinoma - pathology (173) 173
cystadenocarcinoma, serous - secondary (173) 173
neoplasms (170) 170
pancreatic neoplasms - diagnosis (168) 168
health aspects (167) 167
gene expression regulation, neoplastic (157) 157
genetic aspects (157) 157
pancreatic neoplasms - surgery (155) 155
neoplasm invasiveness (152) 152
disease-free survival (151) 151
survival analysis (150) 150
gene expression (147) 147
cystadenocarcinoma, serous - therapy (146) 146
management (143) 143
breast-cancer (140) 140
peritoneal neoplasms - pathology (140) 140
uterine neoplasms - pathology (139) 139
cystadenocarcinoma, mucinous - pathology (138) 138
cystadenoma (133) 133
pancreas (130) 130
risk factors (130) 130
combined modality therapy (129) 129
article (127) 127
sensitivity and specificity (126) 126
case-control studies (125) 125
immunoenzyme techniques (125) 125
ovarian neoplasms - therapy (125) 125
p53 (121) 121
cystadenocarcinoma - diagnosis (120) 120
development and progression (118) 118
gastroenterology & hepatology (116) 116
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2636) 2636
Chinese (58) 58
French (39) 39
German (37) 37
Japanese (33) 33
Russian (11) 11
Spanish (7) 7
Italian (5) 5
Hungarian (4) 4
Polish (4) 4
Danish (3) 3
Czech (2) 2
Korean (2) 2
Portuguese (2) 2
Romanian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Dutch (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Advances in Anatomic Pathology, ISSN 1072-4109, 09/2009, Volume 16, Issue 5, pp. 267 - 282
Ovarian serous carcinomas have been graded using various systems. Recently, a 2-tier system in which tumors are subdivided into low grade and high grade has... 
Serous carcinoma | Ovary | Grading | High grade | Low grade | DIFFERENTIAL-DIAGNOSIS | ACTIVATED PROTEIN-KINASE | GENETIC-ANALYSIS | grading | low grade | FALLOPIAN-TUBE | DRUG-RESISTANCE | PATHOLOGY | INTRAEPITHELIAL CARCINOMA | PAPILLARY CARCINOMA | MUTATIONAL ANALYSIS | ovary | PRIMARY PERITONEAL CARCINOMA | POTENTIAL BORDERLINE TUMORS | serous carcinoma | high grade | Immunohistochemistry | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Cystadenocarcinoma, Serous - metabolism | Ovarian Neoplasms - pathology | ras Proteins - metabolism | Ki-67 Antigen - metabolism | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | Cyclin-Dependent Kinase Inhibitor p16 | Ovarian Neoplasms - genetics | Tumor Suppressor Protein p53 - analysis | Female | Ovarian Neoplasms - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Ovary - metabolism | Proto-Oncogene Proteins - metabolism | Diagnosis, Differential | Ovary - pathology | Ovarian Neoplasms - diagnosis | Tumor Suppressor Protein p53 - metabolism | Proto-Oncogene Proteins - genetics | Ki-67 Antigen - analysis | Proto-Oncogene Proteins B-raf - genetics | Adaptor Proteins, Signal Transducing - genetics | Neoplasm Proteins - analysis | Cystadenocarcinoma, Serous - diagnosis | Mutation | Adaptor Proteins, Signal Transducing - metabolism | low-grade | high-grade
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 10/2009, Volume 33, Issue 10, pp. 1504 - 1514
Uterine serous carcinomas typically have a characteristic morphology (papillary architecture, high-grade nuclei) and immunoprofile (diffuse/strong p53... 
Adenocarcinoma | Immunohistochemistry | P16 | Uterus | Endometrioid carcinoma | Serous carcinoma | Endocervical adenocarcinoma | SURGERY | DIFFERENTIAL-DIAGNOSIS | CERVICAL ADENOCARCINOMAS | FEMALE GENITAL-TRACT | MICROSATELLITE INSTABILITY | adenocarcinoma | DRUG-RESISTANCE | PATHOLOGY | HUMAN-PAPILLOMAVIRUS DNA | OVARIAN-CARCINOMA | uterus | p16 | P53 GENE-MUTATIONS | endocervical adenocarcinoma | immunohistochemistry | PROGNOSTIC-SIGNIFICANCE | serous carcinoma | endometrioid carcinoma | CLEAR-CELL CARCINOMA | Humans | Cystadenocarcinoma, Serous - metabolism | Endometrial Neoplasms - metabolism | Cystadenocarcinoma, Serous - genetics | Carcinoma, Endometrioid - diagnosis | Papillomavirus Infections - diagnosis | Tumor Suppressor Protein p53 - genetics | Carcinoma, Endometrioid - metabolism | Endometrial Neoplasms - genetics | Uterine Cervical Neoplasms - metabolism | DNA Mutational Analysis | Polymerase Chain Reaction | Cyclin-Dependent Kinase Inhibitor p16 - biosynthesis | Female | Uterine Neoplasms - diagnosis | Uterine Neoplasms - genetics | Carcinoma, Endometrioid - genetics | Diagnosis, Differential | Papillomavirus Infections - complications | Uterine Neoplasms - metabolism | Uterine Cervical Neoplasms - diagnosis | Biomarkers, Tumor - analysis | In Situ Hybridization, Fluorescence | Endometrial Neoplasms - diagnosis | Papillomavirus Infections - metabolism | Uterine Cervical Neoplasms - virology | Cystadenocarcinoma, Serous - diagnosis
Journal Article
Modern Pathology, ISSN 0893-3952, 01/2016, Volume 29, Issue 1, pp. S45 - S58
Serous carcinoma (SC) represents similar to 10% of endometrial carcinomas, but is responsible for almost 40% of cancer deaths. This article reviews the main... 
P53 IMMUNOREACTIVITY | CANCERS | PROGNOSIS | ADENOCARCINOMA | PAPILLARY | PATHOLOGY | CLEAR-CELL CARCINOMA | INTRAEPITHELIAL CARCINOMA | EXPRESSION | UTILITY | CLINICOPATHOLOGICAL FEATURES | Female | Cystadenocarcinoma, Serous - diagnosis | Endometrial Neoplasms - diagnosis | Humans
Journal Article
Digestive and Liver Disease, ISSN 1590-8658, 2013, Volume 45, Issue 9, pp. 703 - 711
Journal Article